Huma has raised $80 million in fourth-round financing that will go in part towards rolling out a new platform that can be used by developers to create disease management tools.
Mere months after announcing a partnership to develop digital support tools for cancer patients, Huma Therapeutics and Merck KGaA have launched their first app in the UK.
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.